美国药典USP标准品-胰淀粉酶和蛋白酶(Pancreatin Amylase and Protease)


  【编号】:USP1494057

  【名称】:胰淀粉酶和蛋白酶(Pancreatin Amylase and Protease)

  【规格】:2g

  【价格】:3600元(冷运)

  胰淀粉酶和蛋白酶标准品

  英文名称:Pancreatin Amylase and Protease
  编号:USP-1494057
  规格:2g
  CAS号:8049-47-6
  品牌:美国药典USP标准品
  

美国药典USP标准品CAS编号查询(三十五),USP标准物质代理

USP订购编号 美国药典,USP分析标准品,英文名称,规格 CAS编号查询 UN编号对照
USP-1062020 Benzyl   Disulfide (200 mg) 150-60-7
2930902000
USP-1065209 Berberis   aristata Stem Dry Extract (100 mg) NA
1302190200
USP-1065210 Berberine   Chloride (50 mg) 141433-60-5
2939790000
USP-1065221 Bendamustine   Hydrochloride (200 mg) 3543-75-7 UN2811
USP-1065232 Bendamustine   Related Compound A (25 mg)   (4-{5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid   hydrochloride) 109882-29-3
2933998350
USP-1065243 Bendamustine   Related Compound B (20 mg)   (4-(1-Methyl-5-morpholino-1H-benzimidazol-2-yl)butanoic acid hydrochloride) N/A
2934990005
USP-1065254 Bendamustine   Related Compound C (20 mg) (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H   -benzimidazol-2-yl}butanoate) 3543-74-6
2933998350
USP-1065265 Bendamustine   Related Compound D (20 mg) (4-{5-[(2-Chloroethyl)amino]-1-methyl-1H   -benzimidazol-2-yl}butanoic acid hydrochloride) 1797881-48-1
2933998350
USP-1065276 Bendamustine   Related Compound E (20 mg)   (4-{5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic   acid) 109882-27-1
2933997500
USP-1134288 Citalopram   Related Compound E (25 mg)   (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide   hydrochloride) 62498-71-9
2932996560
USP-1134299 Citalopram   Related Compound F (200 mg) (dimethyl-(1-methyl-3,3-diphenyl-allyl)-amine   hydrochloride) 55011-89-7 UN2811
USP-1134305 Citicoline   Sodium (2 x 350 mg) 33818-15-4
2934990005
USP-1134313 Ciprofloxacin   (200 mg) 85721-33-1 UN3077
USP-1134324 Ciprofloxacin   Ethylenediamine Analog (25 mg)   (1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[(2-aminoethyl)amino]-3-quinolinecarboxylic   acid hydrochloride) 528851-31-2
2933497050
USP-1152600 Cyclamic   Acid (100 mg) 100-88-9
2929909000
USP-1152701 Cyclandelate   (200 mg) 456-59-7
2918191350
USP-1152814 Cyclic   Olefin Polymer (1 g) N/A
3902900050
USP-1154004 Cyclizine   Hydrochloride (200 mg) 303-25-3 UN2811
USP-1154503 Cyclobenzaprine   Hydrochloride (200 mg) 6202-23-9
2921490002
USP-1235106 Emtricitabine   (200 mg) 143491-57-0
2934990005
USP-1235128 Emtricitabine   System Suitability Mixture A (15 mg) N/A
2934990005
USP-1235139 Emtricitabine   System Suitability Mixture B (15 mg) N/A
3822190000
USP-1235240 Emulsifying   Wax (30 mg) N/A
3404200000
USP-1235274 Enalaprilat   (300 mg) 84680-54-6
2933995300
USP-1235300 Enalapril   Maleate (200 mg) 76095-16-4
2933995300
USP-1235332 Enalapril   Related Compound D (25 mg) ((S)-Ethyl   2-[(3S,8aS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl]-4-phenylbutanoate) 115729-52-7
2933790002
USP-1235365 Enalapril   Related Compound H (25 mg)   (1-{N-[(S)-1-Ethoxycarbonyl-3-cyclohexylpropyl]-L-alanyl}-L-proline, maleate   (1:1)) n/a
2933999552
USP-1236700 (-)-Epigallocatechin-3-O-gallate   (20 mg) 989-51-5
2932996560
USP-1236801 Epilactose   (200 mg) 50468-56-9
2940006000
USP-1236833 Lovastatin   Epimer Mixture (25 mg) (Epilovastatin and Lovastatin 1:1 Mixture) N/A
2932206000
USP-1236889 Epinastine   Hydrochloride (250 mg) 108929-04-0 UN2811
USP-1236890 Epinastine   Related Compound A (25 mg)   ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate) 127785-96-0
2933992600
USP-1236970 Epinephrine   (200 mg) 51-43-4 UN2811
USP-1237000 Epinephrine   Bitartrate (200 mg) 51-42-3 UN2811
USP-1237382 Epirubicin   Hydrochloride (200 mg) 56390-09-1
2941906000
USP-1237553 Eplerenone   (250 mg) 107724-20-9
2932202000
USP-1237622 Epoprostenol   Related Compound B (15 mg) (Sodium 5-(diphenylphosphinoyl)pentanoate) N/A
2937500000
USP-1238002 Equilin   (25 mg) 474-86-2
2937230000
USP-1238217 Eprosartan   Mesylate (50 mg)   ((E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid,   monomethanesulfonate) 144143-96-4
2934990005
USP-1238228 Eprosartan   Related Compound A (20 mg)   ((E)-3-(2-butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)acrylic acid   hydrochloride) N/A
2934990005
USP-1238239 Eprosartan   Related Compound B (15 mg) (3-(thiophen-2-yl)propanoic acid) 5928-51-8 UN3261
USP-1238240 Eprosartan   Related Compound C (25 mg) (2-(thiophen-2-ylmethyl)malonic acid) 4475-24-5
2934990005
USP-1238251 Eprosartan   Related Compound D (15 mg) (4-(bromomethyl)benzoic acid) 6232-88-8 UN3261
USP-1238262 Eprosartan   Related Compound E (15 mg) (4-(hydroxymethyl)benzoic acid) 3006-96-0
2918992090
USP-1238512 Beta-3-Asp   Eptifibatide (10 mg)   (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-Beta-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide,   cyclic(1-6)-disulfide) NA
2934990005
USP-1238523 D-Har   Eptifibatide (10 mg)   (N6-Amidino-N2-(3-mercaptopropionyl)-D-lysylglycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide,   cyclic(1-6)-disulfide) NA
2934990005
USP-1238556 3-D-Asp   Eptifibatide (10 mg)   (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide,   cyclic(1-6)-disulfide) NA
2934990005
USP-1238578 6-D-Cys   Eptifibatide (10 mg)   (N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-D-cysteinamide,   cyclic(1-6)-disulfide) NA
2934990005
USP-1239504 Ergoloid   Mesylates (300 mg) 8067-24-1
3003490000
USP-1241007 Ergosterol   (50 mg) 57-87-4 UN2811
USP-1241550 Ergotaminine   (100 mg) 639-81-6
2939690000
USP-1241608 Erlotinib   Hydrochloride (150 mg) 183319-69-9
2933595960
USP-1269232 Famotidine   Related Compound C (25 mg)   (3-[[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide   hydrochloride) 76824-17-4
2934100000
USP-1269243 Famotidine   Related Compound D (25 mg)   (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide) 76824-16-3
2934990005
USP-1349740 Methoxsalen   Related Compound B (25 mg) (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one) 482-27-9
2932202000
USP-1359415 Levetiracetam   Racemic Mixture (15 mg) (1:1 mixture of levetiracetam   S-enantiomer-(2S)-2-(2-oxopyrrolidin-1-yl)butanamide and levetiracetam   R-enantiomer (2R)-2-(2-oxopyrrolidin-1-yl)butanamide) 33996-58-6
2933790002
USP-1359426 Levetiracetam   Related Compound A (20 mg)   ((S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide) 102767-31-7
2924190002
USP-1359437 Levetiracetam   Related Compound B (20 mg) ((S)-2-aminobutanamide hydrochloride) 7682-20-4
2924190002
USP-1359801 Levobunolol   Hydrochloride (200 mg) 27912-14-7
2922504500
USP-1359856 Levocabastine   Hydrochloride (50 mg) 79547-78-7
2933399095
USP-1359867 Levocabastine   Related Compound A (50 mg)   (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic   acid hydrochloride) 80139-91-9
2933399095
USP-1359903 Levocarnitine   (400 mg) 541-15-1
2923900100
USP-1370360 Lorazepam   Related Compound E (25 mg) (6-Chloro-4-(o-chlorophenyl)-2-quinazoline   methanol) 773871-49-1
2933998350
USP-1370462 Losartan   Potassium (150 mg) 124750-99-8
2933290000
USP-1370473 Losartan   Related Compound A (20 mg) (2-Butyl-4-chloro-1H-imidazole-5-carbaldehyde) 83857-96-9 UN3077
USP-1370484 Losartan   Related Compound B (20 mg)   (2-Butyl-4-chloro-(1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl   acetate) 1006062-27-6
2933290000
USP-1370495 Losartan   Related Compound C (20 mg)   (2-Butyl-4-chloro-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde) 114798-36-6
2933290000
USP-1370509 Losartan   Related Compound D (20 mg)   (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol,   potassium salt) N/A
2933290000
USP-1370510 Losartan   Related Compound E (20 mg)   (5-[4′-({2-Butyl-5-[(5-{4′-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol,   potassium salt) N/A
2933290000
USP-1370600 Lovastatin   (125 mg) 75330-75-5
2932206000
USP-1370611 Lovastatin   Related Compound A (20 mg) (4,4a-Dihydrolovastatin) N/A
2933997500
USP-1370655 Lovastatin   Impurity Identification Mixture (30 mg) N/A
3822190000
USP-1370688 Low-substituted   Carboxymethylcellulose Sodium (100 mg) 9004-32-4
3912310000
USP-1370699 Loxapine   N-Oxide (25 mg)   (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide) 25967-34-4
2934990005
USP-1370702 Loxapine   Succinate (125 mg) 27833-64-3 UN2811
USP-1370713 Loxapine   Related Compound A (20 mg)   (3-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine) 3454-96-4
2934990005
USP-1370724 Lufenuron   Related Compound B (15 mg)   (N-[(2,5-Dichloro-4-hydroxyphenyl)carbamoyl]-2,6-difluorobenzamide) N/A
2924210000
USP-1370735 Lufenuron   Related Compound C (15 mg)   (N-[3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl]-2,6-difluorobenzamide) N/A
2924210000
USP-1370746 Lumefantrine   (100 mg) 82186-77-4
2922190900
USP-1370757 Lumefantrine   Related Compound A (25 mg) ((RS,   Z)-2-(Dibutylamino)-2-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol   hydrochloride) NA
2922199695
USP-1437020 Methylprednisolone   Hemisuccinate Related Compound B (50 mg)   (11Beta,21-Dihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl hydrogen   succinate) 77074-42-1
2918992090
USP-1437042 Methylprednisolone   Hemisuccinate Related Compound D (50 mg)   (11Beta,17-Dihydroxy-6alpha-methyl-3,20-dioxopregna-4-en-21-yl hydrogen   succinate) 119657-85-1
2937290000
USP-1437461 Methyl   Salicylate Related Compound A (50 mg) (Dimethyl 4-hydroxyisophthalate) 5985-24-0
2918230000
USP-1437508 Methyl   Stearate (300 mg) 112-61-8
2915700100
USP-1437600 Methylsulfonylmethane   (200 mg) 67-71-0
2930909265
USP-1437701 Terbinafine   Related Compound D (25 mg)   ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]-hept-2-en-4-yn-1-amine   hydrochloride) 877265-33-3
2921490002
USP-1438205 Methyl   Tricosanoate (200 mg) (Tricosanoic acid, methyl ester) 2433-97-8
2915900000
USP-1438318 5-O-Methylvisammioside   (25 mg) 84272-85-5
2938900000
USP-1448967 Mycophenolate   Mofetil Related Compound A (15 mg) (2-Morpholinoethyl   (E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate) 1322681-36-6
2934990005
USP-1448978 Mycophenolate   Mofetil Related Compound B (15 mg)   [(RS)-7-hydroxy-5-methoxy-4-methyl-6-[2-(5-methyl-2-oxo-tetrahydrofuran-5-yl)ethyl]-3H-isobenzofuranyl-1-one] 26675-76-3
2932206000
USP-1448989 Mycophenolate   Sodium (200 mg) 37415-62-6 UN3077
USP-1448990 Myristic   Acid (200 mg) 544-63-8
2915900000
USP-1449008 Myristyl   Alcohol (5 x 100 mg) 112-72-1
2905199095
USP-1449041 Myristylpyridinium   Chloride (25 mg) (1-Tetradecylpyridinium chloride) 2785-54-8 UN2811
USP-1449518 Nabumetone   (200 mg) 42924-53-8
2914500000
USP-1449530 Nabumetone   Related Compound A (15 mg) (1-(6-methoxy-2-naphthyl)-but-1-en-3-one) 127053-22-9
2914500000
USP-1449700 Nadolol   (200 mg) 42200-33-9
2922190900
USP-1449711 Nadolol   Related Compound A (25 mg)   ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) N/A
2909500000
USP-1449722 Nadolol   Related Compound B (25 mg)   ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol) N/A
2909490000
USP-1449733 Nadolol   Related Compound C (25 mg) N/A
2909490000
USP-1449766 Nadolol   Related Compound F (25 mg)   (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol) 2116-22-5
2922199695
USP-1449777 Nadolol   Related Compound G (25 mg)   (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol) 33841-03-1
2922199695
USP-1450007 Nafcillin   Sodium (200 mg) 7177-50-6
2941106000
USP-1605500 Ropivacaine   Hydrochloride (200 mg) 132112-35-7
2933399095
USP-1605512 Ropivacaine   Related Compound A (25 mg) (2,6-dimethylaniline hydrochloride) 21436-98-6
2921490002
USP-1605523 Ropivacaine   Related Compound B (50 mg)   ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride   monohydrate) N/A
2933399095
USP-1605588 Rosavin   (25 mg) ((2E)-3-Phenylprop-2-en-1-yl   6-O-alpha-l-arabinopyranosyl-Beta-D-glucopyranoside) 84954-92-7
2939790000
USP-1605668 Powdered   Rosemary Extract (1 g) 84604-14-8
1302190200
USP-1605680 Powdered   Rosemary Hydrophilic Extract (1 g) 84604-14-8
1302190200
USP-1605817 Rosiglitazone   Maleate (200 mg) 122320-73-4
2934100000
USP-1605828 Rosiglitazone   Related Compound A (25 mg)   ((5Z)-5-{[4-({2-[methyl(2-pyridinyl)amino]ethyl}oxy)phenyl]methylidene}-1,3-thiazolidine-2,4-dione) 160596-25-8
2934100000
USP-1605952 Rosmarinic   Acid (25 mg) 20283-92-5
2918992090
USP-1606004 Rosuvastatin   System Suitability Mixture (15 mg) (A mixture containing rosuvastatin   calcium, rosuvastatin ketone, rosuvastatin lactone and rosuvastatin   diastereomers.) N/A
3822190000